Skip to main content

Advertisement

SpringerLink
Log in

Identification and Verification of Two Novel Differentially Expressed Proteins from Non-neoplastic Mucosa and Colorectal Carcinoma Via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

Recurrence or metastasis of colorectal cancer (CRC) is common following surgery and/or adjuvant therapy, particularly in patients with an advanced stage of the cancer. Identifying key molecular markers of CRC is beneficial for early diagnosis and early treatment, which may eventually improve the prognosis of patients with CRC. Isobaric mass tags for relative and absolute quantification (iTRAQ) in combination with multidimensional liquid chromatography and tandem mass spectrometry (LC-MS/MS) were used to identify differentially expressed proteins between CRC tissues and paired adjacent normal mucosa. Among the 105 patients, adenocarcinoma was the most common CRC subtype, stage III was the most common Tumor-Node-Metastasis stage and high levels of Ki-67 indicated the rapid proliferation of tumor cells in the samples. The LC-MS/MS-based iTRAQ technology identified 271 differentially expressed proteins, with 130 upregulated proteins and 141 downregulated proteins. Bioinformatics analysis revealed that golgin subfamily A member 2 (GOLGA2) and heterogeneous nuclear ribonucleoprotein D0 (hnRNPD) were located in the center of the upregulated protein network, and were closely associated with the development of CRC. The upregulation of GOLGA2 and hnRNPD was further verified in human tissues using western blotting and immunohistochemistry. GOLGA2 and hnRNPD were identified as two novels differentially expressed proteins in human CRC. Furthermore, the LC-MS/MS-based iTRAQ proteomic approach is a useful tool for searching and identifying differentially expressed proteins, and may be used to provide a comprehensive understanding of the processes that mediate the development of CRC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386

    Article  CAS  PubMed  Google Scholar 

  2. Karanikas M, Esebidis A (2016) Increasing incidence of colon cancer in patients <50 years old: a new entity? Ann Transl Med 4(9):164

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108

    Article  PubMed  Google Scholar 

  4. Barton MK (2012) Oxaliplatin in the adjuvant treatment of colon cancer. CA Cancer J Clin 62(1):3–4

    Article  PubMed  Google Scholar 

  5. Lote H, Spiteri I, Ermini L, Vatsiou A, Roy A, McDonald A, Maka N, Balsitis M, Bose N, Simbolo M, Mafficini A, Lampis A, Hahne JC, Trevisani F, Eltahir Z, Mentrasti G, Findlay C, Kalkman EAJ, Punta M, Werner B, Lise S, Aktipis A, Maley C, Greaves M, Braconi C, White J, Fassan M, Scarpa A, Sottoriva A, Valeri N (2017) Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer. Ann Oncol 28:1243–1249

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331(6024):1559–1564

    Article  CAS  PubMed  Google Scholar 

  7. Tao Y, Han T, Zhang T, Sun C (2017) Sulfatase-2 promotes the growth and metastasis of colorectal cancer by activating Akt and Erk1/2 pathways. Biomed Pharmacother 89:1370–1377

    Article  CAS  PubMed  Google Scholar 

  8. Shen T, Yang Z, Cheng X, Xiao Y, Yu K, Cai X, Xia C, Li Y (2017) CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-kappaB signaling pathway. Oncol Rep 37:2095–2100

    Article  CAS  PubMed  Google Scholar 

  9. Huang GL et al (2017) Oncogenic retinoic acid receptor gamma knockdown reverses multi-drug resistance of human colorectal cancer via Wnt/beta-catenin pathway. Cell Cycle:1–8

  10. Wang Z et al (2017) Endothelin promotes colorectal tumorigenesis by activating YAP/TAZ. Cancer Res 77(9):2413–2423

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Chen CL, Chung T, Wu CC, Ng KF, Yu JS, Tsai CH, Chang YS, Liang Y, Tsui KH, Chen YT (2015) Comparative tissue proteomics of microdissected specimens reveals novel candidate biomarkers of bladder Cancer. Mol Cell Proteomics 14(9):2466–2478

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Bouchal P, Roumeliotis T, Hrstka R, Nenutil R, Vojtesek B, Garbis SD (2009) Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis. J Proteome Res 8(1):362–373

    Article  CAS  PubMed  Google Scholar 

  13. Chen RX, Song HY, Dong YY, Hu C, Zheng QD, Xue TC, Liu XH, Zhang Y, Chen J, Ren ZG, Liu YK, Cui JF (2014) Dynamic expression patterns of differential proteins during early invasion of hepatocellular carcinoma. PLoS One 9(3):e88543

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Li Y, Wang X, Ao MH, Gabrielson E, Askin F, Zhang H, Li QK (2013) Aberrant Mucin5B expression in lung adenocarcinomas detected by iTRAQ labeling quantitative proteomics and immunohistochemistry. Clin Proteomics 10(1):15

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Sun CY, Xia GW, Xu K, Ding Q (2010) Application of iTRAQ in proteomic study of prostate cancer. Zhonghua Nan Ke Xue 16(8):741–744

    CAS  PubMed  Google Scholar 

  16. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G (2000) Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet 25(1):25–29

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zhang B, Kirov S, Snoddy J (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33(Web Server issue):W741–W748

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. da Huang W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44–57

    Article  CAS  Google Scholar 

  19. Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K (2017) KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 45(D1):D353–D361

    Article  CAS  PubMed  Google Scholar 

  20. Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M (2016) KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res 44(D1):D457–D462

    Article  CAS  PubMed  Google Scholar 

  21. Orchard S, Ammari M, Aranda B, Breuza L, Briganti L, Broackes-Carter F, Campbell NH, Chavali G, Chen C, del-Toro N, Duesbury M, Dumousseau M, Galeota E, Hinz U, Iannuccelli M, Jagannathan S, Jimenez R, Khadake J, Lagreid A, Licata L, Lovering RC, Meldal B, Melidoni AN, Milagros M, Peluso D, Perfetto L, Porras P, Raghunath A, Ricard-Blum S, Roechert B, Stutz A, Tognolli M, van Roey K, Cesareni G, Hermjakob H (2014) The MIntAct project--IntAct as a common curation platform for 11 molecular interaction databases. Nucleic Acids Res 42(Database issue):D358–D363

    Article  CAS  PubMed  Google Scholar 

  22. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498–2504

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Dai P, Wang Q, Wang W, Jing R, Wang W, Wang F, Azadzoi K, Yang JH, Yan Z (2016) Unraveling molecular differences of gastric Cancer by label-free quantitative proteomics analysis. Int J Mol Sci 17(1)

    Article  PubMed Central  CAS  Google Scholar 

  24. Witkos TM, Lowe M (2017) Recognition and tethering of transport vesicles at the Golgi apparatus. Curr Opin Cell Biol 47:16–23

    Article  CAS  PubMed  Google Scholar 

  25. Potelle S, Klein A, Foulquier F (2015) Golgi post-translational modifications and associated diseases. J Inherit Metab Dis 38(4):741–751

    Article  CAS  PubMed  Google Scholar 

  26. Chang SH, Hong SH, Jiang HL, Minai-Tehrani A, Yu KN, Lee JH, Kim JE, Shin JY, Kang B, Park S, Han K, Chae C, Cho MH (2012) GOLGA2/GM130, cis-Golgi matrix protein, is a novel target of anticancer gene therapy. Mol Ther 20(11):2052–2063

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Nakamura N (2010) Emerging new roles of GM130, a cis-Golgi matrix protein, in higher order cell functions. J Pharmacol Sci 112(3):255–264

    Article  CAS  PubMed  Google Scholar 

  28. Medici D, Hay ED, Olsen BR (2008) Snail and slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Mol Biol Cell 19(11):4875–4887

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Tse JC, Kalluri R (2007) Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 101(4):816–829

    Article  CAS  PubMed  Google Scholar 

  30. Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119(6):1420–1428

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Godde NJ, Galea RC, Elsum IA, Humbert PO (2010) Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions. J Mammary Gland Biol Neoplasia 15(2):149–168

    Article  PubMed  Google Scholar 

  32. Lee SC, Kim OH, Lee SK, Kim SJ (2015) IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/beta-catenin signaling as well as survivin expression. Oncotarget 6(29):27146–27159

    Article  PubMed  PubMed Central  Google Scholar 

  33. Nieto MA (2013) Epithelial plasticity: a common theme in embryonic and cancer cells. Science 342(6159):1234850

    Article  PubMed  CAS  Google Scholar 

  34. Roy E, Bruyère J, Flamant P, Bigou S, Ausseil J, Vitry S, Heard JM (2012) GM130 gain-of-function induces cell pathology in a model of lysosomal storage disease. Hum Mol Genet 21(7):1481–1495

    Article  CAS  PubMed  Google Scholar 

  35. Zhao J, Yang C, Guo S, Wu Y (2015) GM130 regulates epithelial-to-mesenchymal transition and invasion of gastric cancer cells via snail. Int J Clin Exp Pathol 8(9):10784–10791

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Han N, Li W, Zhang M (2013) The function of the RNA-binding protein hnRNP in cancer metastasis. J Cancer Res Ther 9(Suppl):S129–S134

    PubMed  Google Scholar 

  37. Gouble A, Grazide S, Meggetto F, Mercier P, Delsol G, Morello D (2002) A new player in oncogenesis: AUF1/hnRNPD overexpression leads to tumorigenesis in transgenic mice. Cancer Res 62(5):1489–1495

    CAS  PubMed  Google Scholar 

  38. Geng Y, Zhang L, Xu M, Sheng W, Dong A, Cao J, Cao J (2015) The expression and significance of hnRNPD in esophageal squamous cell carcinoma cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 31(12):1659–1663

    CAS  PubMed  Google Scholar 

  39. Kumar M, Matta A, Masui O, Srivastava G, Kaur J, Thakar A, Shukla NK, RoyChoudhury A, Sharma M, Walfish PG, Michael Siu KW, Chauhan SS, Ralhan R (2015) Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer. J Transl Med 13:285

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Trojanowicz B, Brodauf L, Sekulla C, Lorenz K, Finke R, Dralle H, Hoang-Vu C (2009) The role of AUF1 in thyroid carcinoma progression. Endocr Relat Cancer 16(3):857–871

    Article  CAS  PubMed  Google Scholar 

  41. Eder S, Arndt A, Lamkowski A, Daskalaki W, Rump A, Priller M, Genze F, Wardelmann E, Port M, Steinestel K (2017) Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K). Cancer Lett 385:160–167

    Article  CAS  PubMed  Google Scholar 

  42. Zhang Z, Zhou C, Chang Y, Zhang Z, Hu Y, Zhang F, Lu Y, Zheng L, Zhang W, Li X, Li X (2016) Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/beta-catenin pathway to promote growth and metastasis in colorectal cancer. Cancer Lett 376(1):62–73

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

The present study was supported by the National Natural Science Foundation of China (grant no.81273745), the Tianjin Natural Science Foundation (grant no.11JCYBJC10900), Sub Project of Key Projects in Tianjin (grant no.15ZXLCSY00040-08) and Science and Technology Program of Tianjin, China (grant no.16ZXHLSY00120).

Author information

Authors and Affiliations

  1. Department of Military Medical and Health Care, Characteristic Medical Center of Chinese People’s Armed Police Forces, Tianjin, 300162, People’s Republic of China

    Yuru Bai, Jiabao Wang, Zhihua Gao & Erqing Dai

  2. Department of Oncology, Nanjing Jiangning Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu, 211100, People’s Republic of China

    Yuru Bai

Authors
  1. Yuru Bai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jiabao Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhihua Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Erqing Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erqing Dai.

Ethics declarations

Competing Interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bai, Y., Wang, J., Gao, Z. et al. Identification and Verification of Two Novel Differentially Expressed Proteins from Non-neoplastic Mucosa and Colorectal Carcinoma Via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry. Pathol. Oncol. Res. 26, 967–976 (2020). https://doi.org/10.1007/s12253-019-00651-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-019-00651-y

Keywords

Search

Navigation